Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
==================================================================================================================================================

* H. J. Gray
* B. Benigno
* J. Berek
* J. Chang
* J. Mason
* L. Mileshkin
* P. Mitchell
* M. Moradi
* F. O. Recio
* C. M. Michener
* A. Alvarez Secord
* N E. Tchabo
* J. K. Chan
* J. Young
* H. Kohrt
* S. E. Gargosky
* J. C. Goh